基于RNA的癌症治疗方法的进步:临床前和临床影响
Yubo Yan1, Shuang Liu2, Jie Wen3
1Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Molecular cancer
|October 10, 2025
概括
包括mRNA和siRNA在内的RNA疗法通过调节基因表达来彻底改变癌症治疗. 交付和向方面的进展在各种癌症的临床试验中表现有希望,克服了耐药性并改善了结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于RNA的疗法通过调节基因表达来提供癌症治疗的新策略.
- 关键的RNA类型包括信使RNA (mRNA),小干扰RNA (siRNA),microRNA (miRNA),反意义寡核酸 (ASO) 和RNA的亚体.
研究的目的:
- 审查基于RNA的癌症疗法在临床前和临床应用中的最新进展.
- 专注于这些药物的输送策略,生物标和药理学优化.
主要方法:
- 对各种基于RNA的治疗方法的临床前发展和临床试验数据的审查.
- 输送系统的分析,如脂质纳米粒子和化学修饰.
- 检查生物标和药理学优化策略.
主要成果:
- mRNA疗法在癌症免疫疗法和蛋白质替代中显示出潜力.
- siRNA和ASO能够实现精确的基因沉默和拼接校正.
- miRNA疗法提供瘤性途径控制,而RNA吸收酶则作为瘤向剂.
- 传递技术的进步提高了RNA剂的稳定性和有效性.
- 早期临床试验报告了固体瘤和血液恶性瘤的积极结果,包括克服耐药性和调节瘤微环境 (TME).
结论:
- 基于RNA的策略正在向临床瘤学整合迈进,在早期阶段的试验中取得了有希望的结果.
- 需要解决可扩展性,免疫激活和瘤透方面的挑战.
- 持续完善交付技术和试验设计对于个性化癌症治疗至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


